Drug trials based on non-animal testing can cut costs by about 90%: Report
The report emphasizes the advantages of using non-animal methods (NAMs) in drug development, such as significant cost reduction and more ethical and accurate predictions of human outcomes. India, the US, and the UK have approved the use of NAMs, and companies like Dr Reddy's, Sun Pharma, and Biocon are actively adopting them.